Product Dossier

Cefepime-AFT

Product Dossier for Cefepime-AFT (cefepime, AFT Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.

Sponsor: AFT Pharmaceuticals
Active ingredient: cefepime
Therapeutic area: Infectious Disease
Related brand: CEFEPIME KABI
Same area: RETROVIR
Same area: Savacol Antiseptic Mouth & Throat Rinse

What it is

Cefepime-AFT is cefepime hydrochloride monohydrate supplied as powder for injection in vials. The medicine is available in three strengths: 500 mg, 1 g, and 2 g.

Regulatory history

Cefepime-AFT was first registered on the ARTG on 13 February 2013, with all three strengths registered simultaneously. ---

**Note:** The provided source documents do not contain information regarding approved indications, dosing overview, key safety warnings, contraindications, or PBS listing for Cefepime-AFT. A complete Brand Dossier would require additional source documentation covering these clinical and regulatory aspects.